These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 4695046)

  • 1. Differentiation between Mycobacterium kansasii and M. gastri.
    Tsukamura M
    J Gen Microbiol; 1973 Jan; 74(1):193-4. PubMed ID: 4695046
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mycobacterium kansasii and its variants].
    Schröder KH; Magnusson M
    Zentralbl Bakteriol Orig; 1968; 207(4):498-509. PubMed ID: 5742980
    [No Abstract]   [Full Text] [Related]  

  • 3. [Differentiation of slow-growing scotochromogenous mycobacteria].
    Schröder KH; Pfirrmann K; Töpfer M; Hoff K
    Zentralbl Bakteriol Orig; 1971; 216(2):228-38. PubMed ID: 5551866
    [No Abstract]   [Full Text] [Related]  

  • 4. [A study on slow growing chromogenic (Runyon's group II) mycobacteria].
    Pattyn SR; Hermans-Boveroulle MT; van Ermengem J
    Zentralbl Bakteriol Orig; 1968; 207(4):509-16. PubMed ID: 5742981
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro susceptibility of atypical mycobacteria to rifampin.
    Molavi A; Weinstein L
    Appl Microbiol; 1971 Jul; 22(1):23-5. PubMed ID: 5111305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential identification of Mycobacterium kansasii and Mycobacterium marinum.
    Silcox VA; David HL
    Appl Microbiol; 1971 Feb; 21(2):327-34. PubMed ID: 4925535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new mycobacterium species: Mycobacterium asiaticum n. sp.
    Weiszfeiler G; Karasseva V; Karczag E
    Acta Microbiol Acad Sci Hung; 1971; 18(4):247-52. PubMed ID: 5006093
    [No Abstract]   [Full Text] [Related]  

  • 8. Acquired resistance to rifampicin by Mycobacterium kansasii.
    Davidson PT; Waggoner R
    Tubercle; 1976 Dec; 57(4):271-3. PubMed ID: 1014109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Activity of the ansamycins LM 427 and FCE 22250 on atypical mycobacteria in vitro].
    Ungheri D; Morvillo E; Sanfilippo A
    G Ital Chemioter; 1983; 30(2-3):97-100. PubMed ID: 6329872
    [No Abstract]   [Full Text] [Related]  

  • 10. [Photochromogenic strains of Mycobacterium gastri?].
    Anz W; Schröder KH
    Zentralbl Bakteriol Orig; 1970; 214(4):553-4. PubMed ID: 4928441
    [No Abstract]   [Full Text] [Related]  

  • 11. Activity in vitro of rifabutin, FCE 22807, rifapentine, and rifampin against Mycobacterium microti and M. tuberculosis and their penetration into mouse peritoneal macrophages.
    Dhillon J; Mitchison DA
    Am Rev Respir Dis; 1992 Jan; 145(1):212-4. PubMed ID: 1309967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro activities of rifabutine and rifampicin against various mycobacteria, especially Mycobacterium tuberculosis and Mycobacterium avium complex].
    Saito H; Sato K; Tomioka H
    Kekkaku; 1988 Mar; 63(3):167-72. PubMed ID: 2836649
    [No Abstract]   [Full Text] [Related]  

  • 13. Differentiation between Mycobacterium kansasii and Mycobacterium marinum by gas-liquid chromatographic analysis of cellular fatty acids.
    Thoen CO; Karlson AG; Ellefson RD
    Appl Microbiol; 1972 Dec; 24(6):1009-10. PubMed ID: 4650594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A co-operative numerical analysis of Mycobacterium gastri, Mycobacterium kansasii and Mycobacterium marinum.
    Wayne LG; Andrade L; Froman S; Käppler W; Kubala E; Meissner G; Tsukamura M
    J Gen Microbiol; 1978 Dec; 109(2):319-27. PubMed ID: 745004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical mycobacteria isolated from diagnostic material.
    Hajós K; Juhász P
    Acta Microbiol Acad Sci Hung; 1970; 17(4):371-9. PubMed ID: 4998386
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative in vitro activities of rifabutin and rifampicin against various mycobacteria using 7H10 agar and 1% Ogawa egg media].
    Sato K; Saito H; Tomioka H
    Kekkaku; 1988 Sep; 63(9):601-4. PubMed ID: 2854588
    [No Abstract]   [Full Text] [Related]  

  • 17. Activity of the spiropiperidyl rifamycin LM 427 on rifampicin resistant Mycobacterium tuberculosis.
    Ungheri D; Della Bruna C; Sanfilippo A
    G Ital Chemioter; 1984; 31(3):211-4. PubMed ID: 6100178
    [No Abstract]   [Full Text] [Related]  

  • 18. Rifampin resistance in Mycobacterium kansasii is associated with rpoB mutations.
    Klein JL; Brown TJ; French GL
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3056-8. PubMed ID: 11600355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Mycobacterium kansasii by susceptibility to hydroxylamine.
    Gruft H; Osterhout M
    Appl Microbiol; 1970 Jan; 19(1):199-200. PubMed ID: 4905946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of lipophilicity on the antibacterial activity of rifamycins.
    Pelizza G; Lancini GC; Allievi GC; Gallo GG
    Farmaco Sci; 1973; 28(4):298-315. PubMed ID: 4144627
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.